Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-21

FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ciclopirox Olamine from Cosette Pharmaceuticals, resulting in updated labeling for its topical antifungal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclopirox olamine (Ciclopirox olamine)

Snippet

SUPPL AP for CICLOPIROX OLAMINE (CICLOPIROX OLAMINE)